Riluzole
Product Description
CZECH-GEN
-
Country/Region:Czech Republic
-
Founded:1992
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
CZECH-GEN
-
Country/Region:Czech Republic
-
Founded:1992
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from CZECH-GEN (16)
-
Product Butamirate citrate
Butamirate Citrate – API for Respiratory Applications
Butamirate Citrate is a centrally acting, non-opioid antitussive agent that suppresses the cough reflex without causing opioid-related dependence.
Therapeutic Applications: Symptomatic treatment of dry, non-productive cough
M... -
Product Dofetilide
Dofetilide – Antiarrhythmic API
Dofetilide is an active pharmaceutical ingredient (API) belonging to the class of Class III antiarrhythmic agents, acting as a selective blocker of cardiac potassium channels.
Therapeutic Applications: Maintenance of normal sinus rhythm in patients with... -
Product Chlorprothixene hydrochloride
Chlorprothixene Hydrochloride – API for Psychiatric Applications
Chlorprothixene Hydrochloride is an active pharmaceutical ingredient (API) belonging to the thioxanthene class of first-generation antipsychotics.
Therapeutic Applications:
• Schizophrenia and other psychotic disorders q... -
Product Eszopiclone
Eszopiclone – API for Insomnia Treatment
Eszopiclone is an active pharmaceutical ingredient (API) belonging to the class of non-benzodiazepine hypnotics that act as positive allosteric modulators of GABA-A receptors.
Therapeutic Application: Treatment of insomnia... -
Product Moxonidine (CEP grade)
Moxonidine – API for Hypertension Treatment
Moxonidine is an active pharmaceutical ingredient (API) belonging to the class of centrally acting imidazoline I1-receptor agonists.
Therapeutic Application: Treatment of essential hypertension
Manufactured ... -
Product Regadenoson
Regadenoson – API for Cardiac Stress Testing
Regadenoson is an active pharmaceutical ingredient (API) belonging to the class of selective adenosine A2A receptor agonists.
Diagnostic Application: Pharmacological stress testing for myocardial perfusion imaging (MPI) in patients unable t... -
Product Tizanidine hydrochloride
Tizanidine Hydrochloride – API for Muscle Relaxant Applications
Tizanidine Hydrochloride is an active pharmaceutical ingredient (API) belonging to the class of centrally acting α2-adrenergic receptor agonists.
Therapeutic Application: Management of muscle spasticity, including increas... -
Product Warfarin sodium salt
Warfarin Sodium Salt (Clathrate) – API for Anticoagulant Therapy
Warfarin Sodium Salt (Clathrate) is an active pharmaceutical ingredient (API) belonging to the class of vitamin K antagonist anticoagulants.
Therapeutic Application: Prevention and treatment of thromboembolic... -
Product Zolpidem tartrate (CEP grade)
Zolpidem Tartrate (CEP Grade) – Sedative and Hypnotic API
Zolpidem Tartrate is an active pharmaceutical ingredient (API) belonging to the class of non-benzodiazepine hypnotics (Z-drugs) that act as positive allosteric modulators of GABA-A receptors.
Therapeutic Application: Short-... -
Product Zopiclone (CEP grade)
Zopiclone – Sedative and Hypnotic API
Zopiclone is an active pharmaceutical ingredient (API) belonging to the class of non-benzodiazepine hypnotics (Z-drugs) that act as positive allosteric modulators of GABA-A receptors.
Therapeutic Application: Short-term treatment of insomnia.
... -
Product Hymecromone
Hymecromone – API for Biliary Tract Disorders
Hymecromone is an active pharmaceutical ingredient (API) belonging to the class of coumarin derivatives with choleretic and biliary antispasmodic properties.
Therapeutic Application: Symptomatic treatment of functional biliary tract disord... -
Product Tizanidine base
Tizanidine Hydrochloride – Skeletal Muscle Relaxant API
Tizanidine Hydrochloride is an active pharmaceutical ingredient (API) belonging to the class of centrally acting α2-adrenergic agonists with skeletal muscle relaxant properties.
Therapeutic Application: Management of muscle spast...
CZECH-GEN resources (1)
-
Brochure FARMAK Presentation
FARMAK Presentation 2020











